Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
The Journal of Orthopaedic and Sports Physical Therapy|January 1, 1989
Effects of varying electrode site placements on the torque output of an electrically stimulated involuntary quadriceps femoris muscle contractionJ P Ferguson, M W Blackley, R D Knight, et al.Experimental Hematology|November 1, 1996
Efficiency of human HLA-mismatched CD34+ cells from unrelated donors in establishing in vitro hematopoiesis in allogeneic long-term marrow culturesV F La Russa, S W Kessler, V A Henson, et al.Leukemia Research|January 1, 1989
Evidence for a factor in normal human serum that induces human neutrophilic granulocyte end-stage maturation in vitroW H Evans, S M Wilson, J M Bednarek, et al.Cancer Research|October 15, 1988
Phase I and clinical pharmacology study of intravenous flavone acetic acid (NSC 347512)R B Weiss, R F Greene, R D Knight, et al.Journal of Molecular and Cellular Cardiology|October 2, 2003
Protective effects of the urocortin homologues stresscopin (SCP) and stresscopin-related peptide (SRP) against hypoxia/reoxygenation injury in rat neonatal cardiomyocytesA Chanalaris, K M Lawrence, A Stephanou, et al.Archives of Internal Medicine|September 12, 1994
Treatment of cancer-associated hypercalcemia. Double-blind comparison of rapid and slow intravenous infusion regimens of pamidronate disodium and saline aloneR Gucalp, R Theriault, I Gill, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2004
Phase I study of an immunomodulatory thalidomide analog, CC-4047, in relapsed or refractory multiple myelomaS A Schey, P Fields, J B Bartlett, et al.Cancer|March 4, 2000
Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trialsA Lipton, R L Theriault, G N Hortobagyi, et al.Journal of Clinical Pharmacology|April 1, 1997
Pharmacokinetics of pamidronate disodium in patients with cancer with normal or impaired renal functionJ R Berenson, L Rosen, R Vescio, et al.The New England Journal of Medicine|December 12, 1996
Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study GroupG N Hortobagyi, R L Theriault, L Porter, et al.Pageof 7